BRCA1 and breast cancer: Whether exogenous estrogens, such as oral contraceptives, modify the BC risk in BRCA1/2 mutation carriers is a controversial topic: while some studies suggest that oral contraceptives may increase the BC risk among BRCA1/2 mutation carriers, others reported only little or no influence of oral contraceptives on the BC risk (Narod et al.